Skip to content

A Randomized Controlled Clinical Trial for Osteopeptides in Treating Early Knee Osteoarthritis

A Randomized Controlled Clinical Trial for Osteopeptides in Treating Early Knee Osteoarthritis

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900025726
Enrollment
Unknown
Registered
2019-09-06
Start date
2019-10-01
Completion date
Unknown
Last updated
2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoarthritis

Interventions

Sponsors

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Early knee osteoarthritis; 2. Aged <= 60 years; there is no limit to men and women; 3. Cartilage injury was found on MRI of knee joint; 4. Agree and sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Secondary KOA; 2. Those complicated with cerebrovascular, liver, kidney, mental diseases and other serious diseases; 3. Suffering from joint tuberculosis, tumor, infectious arthritis, rheumatoid arthritis, ankylosing spondylitis, gout, psoriasis and other systemic diseases; 4. There is a history of knee joint trauma, fracture and operation; 5. Pain attack accompanied by fever; 6. The course of disease is not self-limiting and progressive aggravation; 7. Patients who are unable to complete case data collection and have poor compliance.

Design outcomes

Primary

MeasureTime frame
magnetic resonance imaging T2-mapping imaging;

Secondary

MeasureTime frame
The Western Ontario and McMaster Universities Osteoarthritis Index;

Countries

China

Contacts

Public ContactZheng Yuxin

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

sg_zyx1728@126.com+86 13816256086

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026